Methods for the Preparation of Retroviral Particles and Cell Lines Deficient in the Alpha-Galactosyl Epitope

Details for Australian Patent Application No. 2002320649 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Springhorn, Jeremy P; Fodor, William L; Rollins, Scott A; Rother, Russell P

Agent Cullen & Co

Pub. Number AU-B-2002320649

Parent 40177

Filing date 19 December 2002

Wipo publication date 10 April 2003

Acceptance publication date 10 March 2005

International Classifications

C12P 021/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 039/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

16 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002320649

10 March 2005 Application Accepted

  Published as AU-B-2002320649

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320650-Sliding shelf system with front support posts

2002320648-An Offender Tracking System